Experience of Staying in Intensive Care and Impact on Quality of Life (Expe-Rea)

January 13, 2026 updated by: University Hospital, Strasbourg, France

It now seems well established that post-traumatic stress disorder following a stay in intensive care is one of the factors that affects patients' quality of life after they leave hospital.

Several qualitative and quantitative studies suggest that there are several factors associated with the onset of this post-traumatic stress disorder, including the absence of memory of the stay in intensive care. With this in mind, some intensive care units (in France and abroad) are implementing measures to improve the patient experience during their stay, particularly to compensate for this lack of memory: several studies show a link between the introduction of intensive care unit logbooks and a decrease in the incidence of post-traumatic stress disorder after returning home.

The aim of this research project is to measure the experience of the stay in intensive care and its possible impact on quality of life. It is therefore part of a process of implementing measures within general and cardiovascular surgical intensive care units, aimed at better assessing and improving the quality of life of patients after a stay in intensive care.

Study Overview

Status

Recruiting

Conditions

Study Type

Observational

Enrollment (Estimated)

40

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • France
      • Strasbourg, France, 67091
        • Recruiting
        • Service de Réanimation Chirurgicale - CHU de Strasbourg - France
        • Sub-Investigator:
          • Julien GODET, Statistician
        • Contact:
        • Principal Investigator:
          • Coralie Pauzet, MD
        • Sub-Investigator:
          • Margot TRIBOULET, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Adult patient (≥ 18 years) having a stay in intensive care > 48 hours

Description

Inclusion Criteria:

  • Adult patient (≥ 18 years)
  • Stay in intensive care > 48 hours

Exclusion Criteria:

  • Admission to intensive care following scheduled surgery.
  • Readmission to intensive care (previous admission within the 30 days prior).
  • Patient under legal guardianship
  • Inability to complete a questionnaire
  • Poor reading and/or speaking comprehension of French
  • Patient under guardianship or conservatorship.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
ICE questionnaire score
Time Frame: Between 1 and 3 days after discharge from the intensive care unit.

ICE (Impact Confidence Experience) questionnaire score:

The scores for each letter (I, C, E) are added together or averaged.

The higher the score, the better. This indicates a positive experience, trust, and a significant impact.

Simple example:

  • Impact = 8/10 → The service was very helpful.
  • Trust = 9/10 → I trust this team.
  • Experience = 7/10 → My experience was quite good.

Average ICE score = (8 + 9 + 7) ÷ 3 = 8/10
Between 1 and 3 days after discharge from the intensive care unit.
Quality of life questionnaire score (SF36)
Time Frame: Day 30 after discharge from hospital

The SF-36 is a health questionnaire consisting of 36 questions.

Each dimension receives a score from 0 to 100:

  • 100 = very good quality of life
  • 0 = very poor quality of life
Day 30 after discharge from hospital

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University Hospital, Strasbourg, France

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 23, 2025

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

June 23, 2026

Study Registration Dates

First Submitted

January 5, 2026

First Submitted That Met QC Criteria

January 13, 2026

First Posted (Actual)

January 14, 2026

Study Record Updates

Last Update Posted (Actual)

January 14, 2026

Last Update Submitted That Met QC Criteria

January 13, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 9771

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Post-traumatic Stress Disorder

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saudi Arabia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe